Aegis Wealth Management (Maryland)’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Aegis Wealth Management (Maryland)'s BMY Position: Q2 2026 in Review
Aegis Wealth Management (Maryland) opened a new position in Bristol-Myers Squibb (BMY) in Q2 2026: 5,321 shares worth $307K. The stake represents 0.14% of the portfolio and ranks #125 among its holdings. This is a return to the name: Aegis Wealth Management (Maryland) previously reported a position in BMY as recently as Q4 2025.
Aegis Wealth Management (Maryland) first reported a position in BMY in Q3 2025 and has held it in 3 quarters since. The position peaked at $326K in Q4 2025. 2,501 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Aegis Wealth Management (Maryland) held 5,321 shares of Bristol-Myers Squibb worth $307K as of Q2 2026.
- Bristol-Myers Squibb was a new Aegis Wealth Management (Maryland) position in Q2 2026.
- Bristol-Myers Squibb made up 0.14% of Aegis Wealth Management (Maryland)'s portfolio in Q2 2026, its #125 holding.
- Aegis Wealth Management (Maryland) first reported a position in Bristol-Myers Squibb in Q3 2025 and has held it in 3 quarters since.
- Aegis Wealth Management (Maryland)'s Bristol-Myers Squibb position peaked at $326K in Q4 2025.
- 2,501 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Aegis Wealth Management (Maryland)'s 13F filing for Q2 2026, filed 7 Aug 2026.